Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I, Single-center, Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Next Previous
Trial Profile

A Phase I, Single-center, Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fosdevirine (Primary) ; Atorvastatin; Rosuvastatin; Simvastatin
  • Indications Acute coronary syndromes; Alzheimer's disease; Atherosclerosis; Atrial fibrillation; Cardiovascular disorders; Diabetic cardiomyopathy; Diabetic foot ulcer; Heart failure; HIV-1 infections; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia; Hyperlipoproteinaemia type II; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Low HDL cholesterol; Multiple sclerosis; Neurological disorders; Retinal vascular occlusion; Systemic lupus erythematosus
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline; GSK

Most Recent Events

  • 30 Aug 2010 Trial location (USA) added as reported by ClinicalTrials.gov.
  • 30 Aug 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
  • 09 Jun 2010 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top